Abstract
Traditional influenza surveillance informs control strategies but can lag behind outbreak onset and undercount cases. Wastewater surveillance is effective for monitoring near real-time dynamics of outbreaks but has not been attempted for influenza. We quantified Influenza A virus RNA in wastewater during two active outbreaks on university campuses in different parts of the United States and during different times of year using case data from an outbreak investigation and high-quality surveillance data from student athletes. In both cases, the IAV RNA concentrations were strongly associated with reported IAV incidence rate (Kendall’s tau = 0.58 and 0.67 for University of Michigan and Stanford University, respectively). Furthermore, the RNA concentrations reflected outbreak patterns and magnitudes. For the University of Michigan outbreak, evidence from sequencing IAV RNA from wastewater indicated the same circulating strain identified in cases during the outbreak. The results demonstrate that wastewater surveillance can effectively detect influenza outbreaks and will therefore be a valuable supplement to traditional forms of influenza surveillance.
Synopsis This study provides evidence that detection of Influenza A RNA in wastewater settled solids can be effectively used to track dynamics of influenza A outbreaks in a community.
Competing Interest Statement
Dorothea Duong, Bridgette Hughes, and Bradley J. White are employees of Verily Life Sciences. Marlene K Wolfe previously provided consulting for Verily Life Sciences.
Funding Statement
This study was funded by the CDC Foundation, Stanford University Provost's Office, MDHHS, UMich COE Skunkworks
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of the University of Michigan waived ethical approval for this work (HUM00209156). This study was approved by the Stanford University IRB (57358) with a waiver of informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This manuscript was updated to include a second outbreak of influenza and evidence from sequencing matching clinical and wastewater specimens.
Data Availability
All data produced in the present study are available upon reasonable request to the authors, UM wastewater data is available at https://doi.org/10.15139/S3/TMOEDS and through the Stanford Digital Repository for Stanford (https://purl.stanford.edu/mb859sw3898)
